Predicting T cell recognition of MHC class I restricted neoepitopes

Zeynep Koşaloğlu(La Jolla Institute for Immunology), Manasa Lanka(La Jolla Institute for Immunology), Angela Frentzen(La Jolla Institute for Immunology), Ashmitaa Logandha Ramamoorthy Premlal(La Jolla Institute for Immunology), John Sidney(La Jolla Institute for Immunology), Kerrie Vaughan(La Jolla Institute for Immunology), Jason Greenbaum(La Jolla Institute for Immunology), Paul F. Robbins(National Cancer Institute), Jared J. Gartner(National Cancer Institute), Alessandro Sette(La Jolla Institute for Immunology), Bjoern Peters(La Jolla Institute for Immunology)
OncoImmunology
August 27, 2018
Cited by 100Open Access
Full Text

Abstract

SNV: single nucleotide variant; nsSNV: nonsynonymous single nucleotide variant; ROC: receiver operating characteristic; AUC: area under ROC curve; HLA: human leukocyte antigen; MHC: major histocompatibility complex; PD-1: Programmed cell death protein 1; PD-L1 or CTLA-4: cytotoxic T-lymphocyte associated protein 4.


Related Papers

No related papers found

Powered by citation graph analysis